The most common side effects in trials are gastrointestinal: nausea (around 43% at 12 mg), vomiting (21%), and diarrhoea (33%)
In the UK, semaglutide (Wegovy) and liraglutide (Saxenda) are licensed for weight management, while semaglutide (Ozempic) and liraglutide (Victoza) are approved for type 2 diabetes
Impact of anabolicandrogenic steroids on organ failure
Isshiki K et al
Reassuringly, there is no evidence that the GLP1a drugs (semaglutide, dulaglutide, exenatide, lixisenatide or liraglutide) affect the bioavailability of oral contraceptives, so no additional barrier contraception is needed whilst on these drugs
First, muscle tissue burns significantly more calories than fat tissue at rest